3-128486117-G-C

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_032638.5(GATA2):​c.481C>G​(p.Pro161Ala) variant causes a missense change. The variant allele was found at a frequency of 0.012 in 1,611,704 control chromosomes in the GnomAD database, including 168 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P161L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0083 ( 9 hom., cov: 32)
Exomes 𝑓: 0.012 ( 159 hom. )

Consequence

GATA2
NM_032638.5 missense

Scores

1
4
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:13O:1

Conservation

PhyloP100: 5.21

Publications

28 publications found
Variant links:
Genes affected
GATA2 (HGNC:4171): (GATA binding protein 2) This gene encodes a member of the GATA family of zinc-finger transcription factors that are named for the consensus nucleotide sequence they bind in the promoter regions of target genes. The encoded protein plays an essential role in regulating transcription of genes involved in the development and proliferation of hematopoietic and endocrine cell lineages. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Mar 2009]
GATA2 Gene-Disease associations (from GenCC):
  • deafness-lymphedema-leukemia syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
  • GATA2 deficiency with susceptibility to MDS/AML
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • monocytopenia with susceptibility to infections
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
  • acute myeloid leukemia
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • myelodysplastic syndrome
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0082579255).
BP6
Variant 3-128486117-G-C is Benign according to our data. Variant chr3-128486117-G-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 134465.We mark this variant Benign, oryginal submissions are: {Uncertain_significance=1, Benign=6, other=1, Likely_benign=1}.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00828 (1261/152268) while in subpopulation NFE AF = 0.0139 (946/67996). AF 95% confidence interval is 0.0132. There are 9 homozygotes in GnomAd4. There are 544 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 1261 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GATA2NM_032638.5 linkc.481C>G p.Pro161Ala missense_variant Exon 3 of 6 ENST00000341105.7 NP_116027.2 P23769-1
GATA2NM_001145661.2 linkc.481C>G p.Pro161Ala missense_variant Exon 4 of 7 NP_001139133.1 P23769-1
GATA2NM_001145662.1 linkc.481C>G p.Pro161Ala missense_variant Exon 3 of 6 NP_001139134.1 P23769-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GATA2ENST00000341105.7 linkc.481C>G p.Pro161Ala missense_variant Exon 3 of 6 1 NM_032638.5 ENSP00000345681.2 P23769-1

Frequencies

GnomAD3 genomes
AF:
0.00830
AC:
1263
AN:
152150
Hom.:
9
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00302
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.00582
Gnomad ASJ
AF:
0.0167
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00228
Gnomad FIN
AF:
0.00151
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0139
Gnomad OTH
AF:
0.00717
GnomAD2 exomes
AF:
0.00820
AC:
1984
AN:
241956
AF XY:
0.00825
show subpopulations
Gnomad AFR exome
AF:
0.00259
Gnomad AMR exome
AF:
0.00330
Gnomad ASJ exome
AF:
0.0158
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00210
Gnomad NFE exome
AF:
0.0138
Gnomad OTH exome
AF:
0.00870
GnomAD4 exome
AF:
0.0124
AC:
18130
AN:
1459436
Hom.:
159
Cov.:
36
AF XY:
0.0122
AC XY:
8880
AN XY:
725780
show subpopulations
African (AFR)
AF:
0.00182
AC:
61
AN:
33464
American (AMR)
AF:
0.00382
AC:
170
AN:
44472
Ashkenazi Jewish (ASJ)
AF:
0.0160
AC:
417
AN:
26030
East Asian (EAS)
AF:
0.0000505
AC:
2
AN:
39626
South Asian (SAS)
AF:
0.00289
AC:
248
AN:
85774
European-Finnish (FIN)
AF:
0.00318
AC:
168
AN:
52912
Middle Eastern (MID)
AF:
0.00647
AC:
36
AN:
5566
European-Non Finnish (NFE)
AF:
0.0149
AC:
16507
AN:
1111354
Other (OTH)
AF:
0.00865
AC:
521
AN:
60238
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
1208
2415
3623
4830
6038
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
602
1204
1806
2408
3010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00828
AC:
1261
AN:
152268
Hom.:
9
Cov.:
32
AF XY:
0.00731
AC XY:
544
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.00301
AC:
125
AN:
41546
American (AMR)
AF:
0.00581
AC:
89
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0167
AC:
58
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.00228
AC:
11
AN:
4828
European-Finnish (FIN)
AF:
0.00151
AC:
16
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0139
AC:
946
AN:
67996
Other (OTH)
AF:
0.00662
AC:
14
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
69
137
206
274
343
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0112
Hom.:
3
Bravo
AF:
0.00838
TwinsUK
AF:
0.0170
AC:
63
ALSPAC
AF:
0.0156
AC:
60
ESP6500AA
AF:
0.00318
AC:
14
ESP6500EA
AF:
0.0126
AC:
108
ExAC
AF:
0.00814
AC:
987
Asia WGS
AF:
0.00115
AC:
4
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:13Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:6Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Oct 27, 2016
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Uncertain:1Benign:3
Nov 03, 2021
Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 27, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 18, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

GATA2: BS1, BS2 -

GATA2-related disorder Benign:1
Jun 05, 2020
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Inborn genetic diseases Benign:1
Aug 20, 2024
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Deafness-lymphedema-leukemia syndrome;C3280030:Monocytopenia with susceptibility to infections Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Deafness-lymphedema-leukemia syndrome Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Uncertain
-0.080
CADD
Benign
19
DANN
Benign
0.97
DEOGEN2
Benign
0.30
T;.;T
Eigen
Benign
-0.045
Eigen_PC
Benign
0.090
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Benign
0.78
.;T;T
MetaRNN
Benign
0.0083
T;T;T
MetaSVM
Uncertain
0.51
D
MutationAssessor
Benign
1.8
L;L;L
PhyloP100
5.2
PrimateAI
Uncertain
0.73
T
PROVEAN
Benign
-0.57
N;N;N
REVEL
Uncertain
0.35
Sift
Benign
0.28
T;T;T
Sift4G
Benign
0.47
T;T;T
Polyphen
0.030
B;D;B
Vest4
0.54
MVP
0.75
MPC
1.4
ClinPred
0.028
T
GERP RS
4.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.092
gMVP
0.41
Mutation Taster
=86/14
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34799090; hg19: chr3-128204960; COSMIC: COSV62007567; API